These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5632845)

  • 1. Intestinal plasminogen proactivator and activator after oral administration of proteolytic enzymes.
    Nakahara M; Kawamura T; Itaya S
    Arzneimittelforschung; 1967 Jul; 17(7):859-61. PubMed ID: 5632845
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of orally administered proteolytic enzymes on carbon tetrachloride induced granuloma pouch.
    Innerfield I; Cohen H; Zweil P
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):871-5. PubMed ID: 5959033
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the systemic effect of orally administered bromelin].
    Lang H; Helger R; Lücker P; Breddin K; Hausamen TU; Rick W
    Arzneimittelforschung; 1969 Jun; 19(6):939-44. PubMed ID: 5306618
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydrolysis of L-histidine methyl ester. II. Activity of various proteolytic enzymes with special reference to activators of human plasminogen.
    Cole ER
    Thromb Diath Haemorrh; 1968 Jul; 19(3):334-45. PubMed ID: 4236821
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man.
    Gans H; Subramanian V; John S; Castaneda AR; Lillehei CW
    Ann N Y Acad Sci; 1968 Jun; 146(2):721-36. PubMed ID: 4239441
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fragmentation of human transferrin by proteolytic enzymes].
    Karl M
    Acta Biol Med Ger; 1971; 26(3):599-610. PubMed ID: 4948113
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinolytic and plasminogen activator activity in proteinase fractions from swine leucocytes.
    Stegnar M; Kopitar M; Accetto B; Lebez D
    Acta Med Iugosl; 1973; 27(5):435-47. PubMed ID: 4773098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 11. The activation of human plasminogen.
    Opher AW; Miller JM
    Exp Med Surg; 1964; 22(2):246-54. PubMed ID: 5896505
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the elementary particles of the lamellae of the visual cell outer segments. 1. On the effects of a few proteolytic enzymes and digitonin].
    Matsuo N; Hosoda A
    Nihon Ganka Kiyo; 1966 Mar; 17(3):292-9. PubMed ID: 6006553
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of proteolytic enzymes on blood coagulation].
    Kardash BE; Geĭtman IIa
    Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):31-4. PubMed ID: 7033958
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of fibrinolytic and proteolytic enzymes in subcellular fractions of human granulocytes.
    Prokopowicz J
    Thromb Diath Haemorrh; 1968 Mar; 19(1):84-93. PubMed ID: 5652242
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of topically administered tissue plasminogen activator for intraocular fibrinolysis in dogs.
    Gerding PA; Hamor RE; Ramsey DT; Vasaune S; Schaeffer DJ
    Am J Vet Res; 1994 Oct; 55(10):1368-70. PubMed ID: 7998691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where do the immunostimulatory effects of oral proteolytic enzymes ('systemic enzyme therapy') come from? Microbial proteolysis as a possible starting point.
    Biziulevicius GA
    Med Hypotheses; 2006; 67(6):1386-8. PubMed ID: 16870353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of proteases on plasminogen activator release from isolated perfused dog leg.
    Hijikata A; Hirata M; Kitaguchi H
    Thromb Res; 1980 Dec 1-15; 20(5-6):521-31. PubMed ID: 7015552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.